Pierce™ Anti-DYKDDDDK Affinity Resin
Pierce™ Anti-DYKDDDDK Affinity Resin
Thermo Scientific™

Pierce™ Anti-DYKDDDDK Affinity Resin

Thermo Scientific Pierce Anti-DYKDDDDK Affinity Resinは、in vitroタンパク質発現系、細菌、酵母詳細を見る
製品番号(カタログ番号)数量
A3680310 mL
A368012 mL
A36804100 mL
A400045625 Columns
製品番号(カタログ番号) A36803
価格(JPY)
96,400
Online offer
Ends: 27-Mar-2026
160,800
割引額 64,400 (40%)
Each
お問い合わせください ›
数量:
10 mL
Thermo Scientific Pierce Anti-DYKDDDDK Affinity Resinは、in vitroタンパク質発現系、細菌、酵母、および哺乳類細胞に発現しているDYKDDDDKタグ付きタンパク質を精製および免疫沈降(IP)するための迅速かつ便利な方法を提供します。アミノ酸配列DYKDDDDKKは一般的に「FLAG」として知られ、UltraLink Biosupportに共有結合した高親和性ラットモノクローナル抗体(クローンL5)によって認識されます。UltraLink Biosupportは、剛性、親水性、高度クロスリンク型、共重合性、および多孔性の高結合能レジンです。レジンの多孔性、剛性、および耐久性は、大量のサンプルを扱う中圧高速フロー手法に適しています。

タンパク質精製またはIPでは、N末端またはC末端のDYKDDDDKタグを有するタンパク質含有サンプルにレジンを添加します。DYKDDDDKタグ付タンパク質を捕捉した後、結合した対象のタンパク質を溶出バッファーで解離させる前に、非特異的に結合したタンパク質を洗浄除去できます。Pierce Anti-DYKDDDDK Affinity Resinは、FPLC装置用のスピン精製カラムまたはカートリッジで使用することが推奨されます。

特長:
特異的—独自のベースビーズと特異性の高い抗体はオフターゲット結合を最小限に抑制(低い非特異的結合)
高純度—最適化された結合-洗浄-溶出プロトコルは高純度を実現
高収量—特殊な抗体結合法は高収量を実現
高速—全精製プロトコルは通常40分以内に完了
経済的—精製プロトコルは複数回の再使用を実現
汎用—スピンベース、重力ベース、またはFPLCベースの精製および濃縮法で使用可能
拡張可能—1、5、および50 mLの安定化レジンパッケージサイズで提供されているため、小規模な免疫沈降や大規模な精製が可能

Pierce Anti-DYKDDDDK Affinity Resinの特性:

組成:抗DYKDDDDK抗体が、高度クロスリンク型かつ剛性の担体であるUltraLink Biosupportに共有結合している
粒子径:50~80 µm
pH安定性:1~13
推奨直線速度:<150 cm/時
使用温度:2~30℃。冷凍しないでください
粒子濃度:リン酸緩衝生理食塩水、0.02%アジ化ナトリウム中の50%スラリー、pH 7.5
結合能:≧ 3.0 mg DYKDDDDK-tGFP-Hisタンパク質(約32 kDa)/mL安定化レジン
研究用途にのみご使用ください。診断目的には使用できません。
仕様
形状液体
フォーマット液体
組成50% suspension in PBS containing 0.02% Sodium azide
製品ラインPierce
製品タイプアフィニティー樹脂
数量10 mL
出荷条件湿氷
固定相抗-DYKDDDDKモノクローナル抗体
MatrixAffinity Resin
Unit SizeEach
組成および保存条件
5 mLの安定化レジン。0.02%のアジ化ナトリウムを含有するPBS中の50%のスラリー10 mLとして提供。2~8℃で保存してください。

よくあるご質問(FAQ)

What is the slurry/suspension percentage for your anti-DYKDDDDK ("FLAG") products?

Anti-DYKDDDDK Magnetic Agarose (Cat. Nos. A36797, A36798, A36799B) is offered as a 25% suspension (1 mL of 25% suspension = 0.25 mL of settled beads). UltraLink-based Anti-DYKDDDDK Affinity Resin (Cat. Nos, A36801, A36803, A36804) is offered as a 50% slurry (1 mL of 50% slurry = 0.5 mL of settled resin).

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

What is the binding capacity for your Anti-DYKDDDDH Affinity Resin?

Here is the binding capacity: ≥3.0 mg DYKDDDDK-tGFP-His protein (˜32 kDa)/mL settled resin.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

Can I use your UltraLink-based Anti-DYKDDDDH ("FLAG") Affinity Resin for FPLC purification?

Yes. The UltraLink-based Anti-DYKDDDDH (“FLAG”) Affinity Resin (Cat. Nos. A36801, A36803, A36804) can be used for FPLC purification.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

How do I cleave off the DYKDDDDK ("FLAG") tag after purification?

An enterokinase cleavage site behind the DYKDDDDK (“FLAG”) tag can allow complete removal of the DYKDDDDK (“FLAG”) tag leaving no additional amino acids. We offer EKMax Enterokinase (Cat. Nos. E18001 and E18002) that can be used for this purpose. Subsequently, the EKMax Enterokinase can be removed using EK-Away Resin (Cat. No. R18001), a resin conjugated with soybean trypsin inhibitor, which has high affinity for enterokinase.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

引用および参考文献 (4)

引用および参考文献
Abstract
Structural insights into Ubr1-mediated N-degron polyubiquitination.
Authors:Pan M,Zheng Q,Wang T,Liang L,Mao J,Zuo C,Ding R,Ai H,Xie Y,Si D,Yu Y,Liu L,Zhao M
Journal:Nature
PubMed ID:34789879
The N-degron pathway targets proteins that bear a destabilizing residue at the N terminus for proteasome-dependent degradation(1). In yeast, Ubr1-a single-subunit E3 ligase-is responsible for the Arg/N-degron pathway(2). How Ubr1 mediates the initiation of ubiquitination and the elongation of the ubiquitin chain in a linkage-specific manner through a single E2 ... More
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation.
Authors:Liu R,Zou Z,Chen L,Feng Y,Ye J,Deng Y,Zhu X,Zhang Y,Lin J,Cai S,Tang Z,Liang Y,Lu J,Zhuo Y,Han Z,Ling X,Liang Y,Wang Z,Zhong W
Journal:Cell death & disease
PubMed ID:38233415
Renal cell carcinoma (RCC) is one of the three major malignant tumors of the urinary system and originates from proximal tubular epithelial cells. Clear cell renal cell carcinoma (ccRCC) accounts for approximately 80% of RCC cases and is recognized as a metabolic disease driven by genetic mutations and epigenetic alterations. ... More
Increased levels of eIF2A inhibit translation by sequestering 40S ribosomal subunits.
Authors:Grove DJ,Levine DJ,Kearse MG
Journal:Nucleic acids research
PubMed ID:37602404
eIF2A was the first eukaryotic initiator tRNA carrier discovered but its exact function has remained enigmatic. Uncharacteristic of translation initiation factors, eIF2A is reported to be non-cytosolic in multiple human cancer cell lines. Attempts to study eIF2A mechanistically have been limited by the inability to achieve high yield of soluble ... More
Brain-enriched RagB isoforms regulate the dynamics of mTORC1 activity through GATOR1 inhibition.
Authors:Figlia G,Müller S,Hagenston AM,Kleber S,Roiuk M,Quast JP,Ten Bosch N,Carvajal Ibañez D,Mauceri D,Martin-Villalba A,Teleman AA
Journal:Nature cell biology
PubMed ID:36097071
Mechanistic target of rapamycin complex 1 (mTORC1) senses nutrient availability to appropriately regulate cellular anabolism and catabolism. During nutrient restriction, different organs in an animal do not respond equally, with vital organs being relatively spared. This raises the possibility that mTORC1 is differentially regulated in different cell types, yet little ... More